2500 tumor samples to unlock secrets of drug resistance
NCT ID NCT03347318
First seen Mar 19, 2026 · Last updated Apr 30, 2026 · Updated 1 time
Summary
This study aims to learn why certain solid tumors stop responding to targeted therapies. Researchers will collect blood, saliva, and tumor tissue from 2500 people with various cancers, including colorectal, breast, lung, and rare tumors. By analyzing the genetic makeup of these samples and testing them in mice, they hope to find patterns that predict treatment success or failure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
A.O. Città della Salute e della Scienza di Torino - Presidio ospedaliero Ostetrico Ginecologico Sant'Anna
Turin, Italy
-
AOU Città della Salute e della Scienza di Torino - Presidio Molinette
Turin, Italy
-
AOU S. Luigi Gonzaga
Orbassano, Italy
-
Azienda Ospedaliera Niguarda Ca'Granda
Milan, Italy
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Italy
-
Azienda Ospedaliero-Universitaria Careggi
Genova, Italy
-
Fondazione IRCCS - Istituto Nazionale dei Tumori
Milan, Italy
-
IEO - Istiuto Europeo di Oncologia
Milan, Italy
-
IOV - Istituto Oncologico Veneto
Padova, Italy
-
Istituto Di Candiolo - Fondazione Del Piemonte Per L'Oncologia (FPO-Irccs)
Candiolo, Italy
-
Ospedale Mauriziano Umberto I
Turin, Italy
-
Ospedale Regionale Umberto Parini
Aosta, Italy
-
Policlinico S.Orsola Malpighi
Bologna, Italy
-
Policlinico Universitario Campus Biomedico
Roma, Italy
-
Presidio Ospedaliero Martini
Turin, Italy
Conditions
Explore the condition pages connected to this study.